Evidence map›Paper›PMID 19281904›Full record

ReviewThe Journal of allergy and clinical immunology2009

Advances in mechanisms of asthma, allergy, and immunology in 2008.

Joshua A Boyce, David Broide, Kenji Matsumoto, Bruce S Bochner

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 44 citations in OpenAlex.

  1. Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  2. Developing PI3K Inhibitors for Respiratory Diseases.Current topics in microbiology and immunology · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Role of Interferon-λ in Allergic Asthma.Journal of innate immunity · 2015
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Joshua A BoyceDepartment of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass, USA.
David Broide
Kenji Matsumoto
Bruce S Bochner
Brigham and Women's Hospital · USJohns Hopkins Medicine · USNational Center For Child Health and Development · JPUniversity of California, San Diego · US

Funding

Targeting Siglec-8/Siglec-F Reduce Allergic Responses In Vitro and In VivoR01AI072265 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BOCHNER, BRUCE S · 2007 to 2017
$3.9M
BASIC AND CLINICAL IMMUNOLOGYT32AI007056 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BOCHNER, BRUCE S · 1985 to 2012
$2.9M
NIAID NIH HHS R01 AI072265NIAID NIH HHS T32 AI007056
6 · The paper itself

Abstract

This review summarizes selected articles appearing in 2008 in the Journal. Articles chosen include those improving our understanding of mechanisms of allergic diseases by focusing on human basophil, mast cell, and eosinophil biology; IgE and its high-affinity receptor on various cells; novel properties of omalizumab; airways remodeling; and genetics. Articles from other journals have been included to supplement the topics presented.

Indexed as

AnimalsAntibodies, Anti-IdiotypicAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAsthmaBasophilsCell DegranulationEosinophilsGenetic Predisposition to DiseaseHumansHypersensitivityImmunoglobulin EInflammation MediatorsMast CellsOmalizumabAntibodies, Anti-IdiotypicAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedImmunoglobulin EInflammation MediatorsOmalizumab

Identifiers

PMID19281904
PMCPMC2671063
OpenAlexW4235063297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.